A small clinical trial in the Netherlands found that a fecal transplant from a lean donor can temporarily improve insulin resistance in obese men — but only half of the recipients responded. Upon further investigation, the researchers discovered that they could predict the success of the treatment by analyzing each patient’s fecal gut-bacterial makeup. This understanding could help shape the development of personalized fecal transplant for diabetes.
